Hck isoform that is nonraft-associated. We have shown using several gain and loss of acylation alleles that dual acylation of Hck was required for CXCL12-mediated chemotaxis in J.CaM 1.6 cells. These results highlight the importance of the unique microenvironment provided by lipid rafts and their specific contribution in providing specificity to CXCL12 signaling. J. Leukoc. Biol. 84: 000 -000; 2008.
INTRODUCTION
Chemokines are small, soluble, proinflammatory molecules that induce chemotaxis in responsive cells. They play a key role in a wide variety of biological processes by regulating cell migration and recruitment. Deregulation of chemokine signaling can alter cell recruitment, promoting the pathogenic states associated with various inflammatory disorders [1, 2] .
Stromal cell-derived factor-1 (SDF-1; now referred to as CXCL12) is a member of the CXC chemokine subgroup that is produced by several tissues and organs in the body, including bone marrow, lymph node, muscle, and various fibroblasts [3] . CXCL12, by binding to its cognate G-protein-coupled receptor CXCR4, has a vital role in the trafficking, homing, and retention of hematopoietic cells, including lymphoid, myeloid, and CD34-positive stem and progenitor cells [4] . Lymphopoiesis and myelopoiesis are dramatically impaired in mice that are deficient for CXCL12 or CXCR4 [4] . In addition, the CXCL12/ CXCR4 axis has been implicated as having a major role in the metastatic behavior of cancer cells [3] . There are a number of intracellular signaling mediators that have been shown to be activated by CXCL12, including Cbl [5, 6] , CD45 [7] , p62Dok [8] , and the nonreceptor Src-family of protein tyrosine kinases (SFK) [9, 10] , but their exact roles in modulating chemotaxis is unclear.
The SFK are a family of proteins that have been implicated in relaying signals downstream of a wide variety of cell-surface receptors to regulate diverse cellular responses including proliferation, differentiation, cell survival, changes in cellular architecture, and regulating cell adhesion and migration [11, 12] . There are now studies to highlight the importance of different SFK in mediating chemotaxis. The SFK, hematopoietic cell kinase (Hck), and Fgr are essential for neutrophil migration, and Lyn is required for the chemotaxis of primary hematopoietic cells [13, 14] .
Membrane association, although not required for its enzymatic activity, is critical for the biological activity of the SFK [15] [16] [17] . Association with cellular membranes is a function of the extreme N terminus of all SFK, which are myristoylated on an invariant amino-terminal glycine residue via an amide bond [18] . Although myristoylation is necessary for membrane association, the SFK require a second membrane localization signal-a polybasic region or a second acylation modification [18] . Palmitoylation occurs via a thioester bond to conserved cysteine resides at Positions 3 and/or 5 for some of the members of the family [18] . Palmitoylation is not only involved in membrane binding but is also necessary for targeting the SFK to distinct plasma membrane microdomains known as lipid rafts [19, 20] , which are specialized regions within the plasma membrane that have a unique lipid and protein composition from adjacent regions and are dependent on membrane cholesterol for their formation [21, 22] . These specialized membrane microdomains have a role in a wide array of cellular processes, including transcytosis, potocytosis, an alternative route of endocytosis and phagocytosis, internalization of pathogens, cholesterol transport, calcium homeostasis, protein sorting, and signal transduction [23, 24] .
There is now accumulating evidence that lipid rafts are involved in regulating CXCL12-CXCR4 signaling [25] [26] [27] [28] [29] [30] [31] . Cholesterol depletion studies have demonstrated inhibition of HIV-1 infection in T cells [25] [26] [27] 29] . This observed inhibition of HIV infection has been attributed to the destabilization of the lipid rafts and its associated proteins, such as CXCR4, a coreceptor for HIV-1. In addition CXCR4 has been shown to localize to lipid rafts within the leading edge of polarized T lymphocytes, and cholesterol depletion of lymphocytes impaired CXCL12-mediated cell migration [31] . The role of SFK and their respective membrane association in mediating cellular responses to chemokines, such as CXCL12, has not been investigated thus far. In the current study, we have used a combination of pharmacological and genetic approaches to investigate the requirement for SFK and their specific subcellular localization to lipid rafts in mediating CXCL12 responsiveness in a T cell model that is deficient in Lck, the major SFK in this cell type.
MATERIALS AND METHODS

Plasmids, antibodies, and reagents
The Hck cDNA constructs used in this study have been described in detail previously [19] . They include wild-type p59 and p61 alleles as well as p59 Gly 2 to Ala 2 (p59G2A), p59 Cys 3 to Ser 3 (p59C3S), and p61Gly 3 to Cys 3 (p61G3C). Hck mAb that detects all of the Hck constructs were purchased from Upstate Biotechnology (Lake Placid, NY, USA). A mAb to actin (Chemicon, Temecula, CA, USA) was used as a loading control. Flotillin-2 mAb (Transduction Laboratories, Lexington, KY, USA) and pyruvate kinase antibody (Chemicon) were used as a raft and cytosolic marker, respectively. Src kinase inhibitors PP1, PP2, and SU6656 were purchased from Calbiochem (San Diego, CA, USA). Methyl-␤-cyclodextrin (M␤CD) was purchased from Sigma Chemical Co. (St. Louis, MO, USA). The chemically synthesized chemoattractant CXCL12 was purchased from Upstate Biotechnology. CXCL12 was prepared as a stock of 0.1 g/l using LPS-free water and 0.1% BSA. A mAb to CXCR4, 12G5 (BD Biosciences, Mississauga, Ontario, Canada), was used for the flow cytometry studies. All secondary antibodies conjugated to HRP (mouse, rabbit, goat) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The PE-conjugated mouse secondary antibody used in the flow cytometry studies was purchased from Molecular Probes (Eugene, OR, USA).
Cell culture and establishment of Hck-expressing J.CaM 1.6 cells (Invitrogen, Mississauga, Ontario, Canada), supplemented with 10% heatinactivated FBS (Invitrogen, Mississauga, Ontario, Canada), 1% penicillinstreptomycin (Invitrogen, Burlington, Ontario, Canada), 1 mM sodium pyruvate (Invitrogen, Mississauga, Ontario, Canada), and 50 M ␤-ME at 37°C in a 5% CO 2 atmosphere. J.CaM 1.6 cells were transfected with the plasmid pLNCX and/or pBabe containing the wild-type and the differentially targeted mutant versions of Hck cDNA (described in ref. [19] ) by electroporation. For each of the constructs, 1 ϫ 10 6 cells were harvested, washed once in serum-free medium, and then incubated with 20 g linearized plasmid for 10 min at room temperature. The cells were then electroporated at 450 volts and 1050 F, with a resistance setting of ϱ using the BioRad Gene Pulser II (Hercules, CA, USA). After electroporation, the cells were allowed to recover for 48 h in serum-containing media and then diluted in 1 mg/ml G418 (Invitrogen, Burlington, Ontario, Canada) or 0.5 g/ml puromycin containing RPMI complete. Individually selected clones were screened for protein expression by Western blot analysis.
Preparing whole cell extracts and Western blotting
The cell lysates were prepared as described previously [19] . Briefly, cells were washed once in cold PBS and lysed in 1% Nonidet P-40 (NP-40) lysis buffer [50 mM HEPES (pH 7.5), 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA, 100 mM NaF, 10% glycerol, 1% NP-40, 1 mM sodium vanadate, 1 mM PMSF, 10 g/ml aprotinin, and leupeptin] and incubated on ice for 20 min. Nuclei and any unlysed cells were removed from the lysates by low-speed centrifugation at 3000 rpm for 10 min. The total protein content in the postnuclear supernatant was determined using bicinchoninic assay (Pierce, Rockford, IL, USA). Protein (100 g) from each sample was separated using 10% SDS-PAGE. The proteins were transferred on a nitrocellulose membrane at 800 mAmps for 2 h. The blots were incubated in blocking buffer composed of Tris-buffered saline (5 mM Tris, 35 mM NaCl, 5 mM KCl) containing 0.1% Tween-20 and 0.5% NP-40 with 5% nonfat milk for 30 min. The blots were then incubated with the primary antibody for 1 h at room temperature (Hck antibody at 1:1000, actin antibody at 1:10,000, flotillin-2 at 1:1000). The blots were then washed 3ϫ 10 min in Tris-buffered saline and then incubated with the appropriate secondary antibody conjugated to HRP antibody at 1:10,000 for 30 min, followed by 3ϫ 10 min washes. All blots were developed according to standard ECL methods.
Lipid raft isolation
The relative insolubility of lipid rafts in cold, nonionic detergent is used as a basis for purification of lipid rafts as described previously [19, 32] . Briefly, 5 ϫ 10 7 cells were harvested in 1 ml cold 1% Triton X-100/modified bovine serum lysis buffer. The lysates were dounced, homogenized, and adjusted to a final sucrose concentration of 40%. A 5-30% continuous sucrose gradient is overlayered on the lysate. The samples were centrifuged overnight at 37,000 rpm at 4°C. As a result of their unique buoyant density, lipid rafts float up the sucrose gradient and are largely separated from soluble proteins. The raft fraction and the soluble fractions were collected and separated using 10% SDS-PAGE. Standard Western blot methods were used to analyze raft targeting of all constructs used in this study.
Flow cytometry
Cells/sample (1ϫ10 6 ) were washed once in FACS buffer (1% FBAϩ0.01% sodium azide in PBS) and then suspended in 100 l FACS buffer containing primary antibody 12G5. The cells were incubated with the primary antibody or isotype control for 30 min on ice, followed by three washes in 1 ml cold FACS buffer. Cells were then suspended in 100 l FACS buffer containing PEconjugated mouse secondary antibody and incubated on ice for 20 min. The cells were washed 3ϫ in 1 ml FACS buffer, followed by final resuspension in 0.5 ml 0.5% formaldehyde in PBS before analyzed for surface expression of CXCR4.
Migration assay
The 48-well microchemotaxis chamber (AP48) from Neuro Probe (Gaithersburg, MD, USA) was used for all of the migration assays. The cells were grown under ideal conditions and diluted to 1.2 ϫ 10 5 cells/ml using RPMI media containing all supplements. For the dose-response experiment, various concentrations of CXCL12 were prepared using serial dilutions. In all experiments with the J.CaM 1.6 clones expressing Hck wild-type and mutant proteins, an optimal concentration of 100 ng/ml CXCL12 was used as a chemoattractant. This concentration was determined in a dose-response experiment. For the migration assay, 25 l of the control media and CXCL12-containing media were added to the lower chamber. In experiments with Jurkat and J.CaM 1.6 cells, a polycarbonate membrane of pore size 5 m was used; for U937 cells, a pore size of 8 m was used. Cells/ml (ϳ6000 cells; 50 l 1.2ϫ10 5 ) were added to the upper chamber, which was assembled according to the manufacturer's instruction and incubated at 37°C, 5% CO 2 , for 1 h. For analysis, the contents of the upper well were aspirated, the chamber was disassembled carefully, and the contents of the lower well were pipetted several times. An aliquot of 10 l cell suspension was used to count the number of cells using a hemocytometer. This number was used to calculate the total number of cells in 25 l media. For each test condition, six replicates were performed.
For migration assays using the inhibitors, the cells were preincubated with the described concentration of inhibitor for 30 min before being used in the assay. To ensure that the only gradient present during the assay is that of the chemoattractant, the same concentration of the inhibitor was present in the upper as well as in the lower chamber.
Statistical analysis
The results of the migration assays are denoted as mean number of cells migrating to control or chemoattractant-containing media Ϯ SEM. Each experiment was done in six replicates at least three times. Multiple range comparisons of the mean relative numbers of migrating cells were made using the Newman-Keuls tests after the ANOVA test (at Pϭ0.001). Data sets that did not overlap with the described datasets (PϽ0.01) were marked with an asterisk to denote statistical significance.
RESULTS
SFK are required for CXCL12-mediated chemotaxis
The functional requirement for SFK in mediating chemokinedependent chemotaxis is somewhat controversial. There is evidence to suggest that the SFK are involved, but the identity of the specific family member involved and its functional requirement are unknown [6, 9, 10, 33] . To address the specific role of SFK in CXCL12-mediated chemotaxis, we used a pharmacological and genetic approach. First, we assessed whether different SFK-selective inhibitors were able to abrogate CXCL12-mediated chemotaxis in two different cell-based systems. We show that PP1 (10 M) and SU6656 (10 M) were able to significantly abrogate CXCL12-mediated chemotaxis of the human myelomonocytic cell line U937 using a neuroprobe chemotaxis chamber assay. The inactive analog of PP1, PP3 was unable to abrogate the CXCL12-mediated chemotaxis observed in the U937 cell line (Fig. 1A) . In addition, the three selective SFK inhibitors (PP1, PP2, and SU6656) were able to significantly inhibit CXCL12-mediated chemotaxis of the Jurkat human T cell lymphoma cell line (Fig. 1B) .
To evaluate the role of SFK using a genetic approach, we examined whether the Jurkat cell-line derivative, J.CaM 1.6, which is deficient in Lck, a major SFK in T lymphocytes, is defective in its ability to respond to CXCL12. As can be seen in Figure 1C , the Jurkat cells migrated to CXCL12 with a maximal response at 100 ng/ml, whereas the Lck-deficient J.CaM 1.6 cells were compromised for their ability to migrate toward CXCL12, independent of the concentration of CXCL12 used. However, it is clear that at the higher concentrations (150 ng/ml and 300 ng/ml) of chemokine, the difference in migratory ability between the two cell types is not as distinct. For all future experiments, we have used 100 ng/ml CXCL12, where there is a maximal biological response for the Jurkat cells and significant difference in the chemotaxis index between the Jurkat and J.CaM 1.6 cells. The inability of J.CaM 1.6 cells to respond to CXCL12 did not appear to be a result of a reduction in its cognate receptor CXCR4, as the Jurkat cells and J.CaM 1.6 cells had similar levels, as detected by flow cytometry (Fig.  1D) . To ensure that CXCR4 was mediating the biological response to CXCL12, in our assay, we demonstrated that a CXCR4-neutralizing antibody was able to block CXCL12-mediated chemotaxis of the Jurkat cell line. Although the pharmacological inhibitor-treated Jurkat T cells and the Lckdeficient J.CaM 1.6 cells respond to CXCL12 in a compromised manner, it is nevertheless not nonexistent, and the cells did respond to some varying degree. This was also evident in assays using neutralizing antibodies, where significant reduction of CXCL12-mediated chemotaxis was observed, but it did not reduce it to control levels. The most likely explanations to the observed chemotactic response are a possibility of a SFKindependent pathway or that CXCL12 has an alternative receptor that uses different effectors. One example of an alternative CXCL12 receptor would be CXCR7/RDC1, which has properties consistent with CXCL12 responsiveness [34 -37] . However, we were not able to detect cell-surface expression of CXCR7 on the Jurkat and J.CaM 1.6 cells using flow cytometry, making the latter possibility less likely (data not shown).
The pharmacological data and genetic data suggested that the SFK, including Lck, were required for CXCL12-mediated chemotaxis, which is consistent with a previous study [9] but differs from other reports [6, 10] . It is currently unclear why there are these discrepancies but is probably reflected in the concentration of CXCL12 that is used, as at higher concentrations, the overall chemotactic response between the two cell lines is not as dramatic (Fig. 1C) . All of our studies have been optimized for the maximal CXCL12 response using the Jurkat cell line as the model of choice.
p59
Hck is able to reconstitute CXCL12-mediated chemotaxis in J.CaM 1.6 cells
We and others [19, 38] have shown previously that the SFK, Hck, has two naturally occurring isoforms that are generated by alternative sites of translational initiation and differ in their amino-terminal sequences, resulting in differential acylation. The p61
Hck isoform contains a single myristic acid moiety, whereas the smaller isoform, p59
Hck , contains myristic acid and palmitic acid moieties within its extreme N terminus. One of the differences between these two isoforms is the selective association of p59
Hck with lipid rafts based on this dual acy-lation [19] . Thus, the two different isoforms of Hck would represent an ideal model SFK to test the hypothesis that the specific localization of SFK, based on their differential acylation, is functionally important with respect to CXCL12-mediated chemotaxis.
To test our hypothesis, we needed to establish that Hck, a SFK that is not normally expressed in T lymphocytes (including Jurkat and J.CaM 1.6 cell line), could complement the Lck-deficient J.CaM 1.6 cell line and therefore act as a model SFK in mediating responsiveness to CXCL12. As can be seen in Figure 2A (and Supplementary Fig. 1 ), the ectopic expression of p59
Hck in three independent clones (3, 10, and 32) of J.CaM 1.6 cells was able to rescue the ability of these cells to migrate toward CXCL12. In contrast, the monoacylated isoform of Hck, p61
Hck , in three independent clones was unable to complement the J.CaM 1.6 cells, despite being expressed at similar or even elevated levels (Fig. 2, A and B, and Supplementary Fig. 1) . The restoration of a chemotactic response by p59
Hck in J.CaM 1.6 cells was similar to the chemotactic response observed with the parental Jurkat cells (data not shown). p59
Hck -expressing cells were unable to migrate toward CXCL12 in the presence of SFK inhibitor SU6656, suggesting that the kinase activity of Hck is required for restoration of chemotaxis ( Supplementary Fig. 2 ). These data suggested that dual acylation of Hck is required for CXCL12-mediated chemotaxis. -treated U937 cells were assessed for migration toward 100 ng/ml CXCL12 using a neuroprobe chemotaxis chamber. The numbers of cells that migrated to the lower chamber were counted in a hemocytometer (four fields of view). The migration assay shown is a representative of three independent experiments and is presented as mean Ϯ SEM (*, PϽ0.01, compared with control CXCL12-treated U937 cells). (B) Control, PP1 (10 M)-, PP2 (10 M)-, and SU6656 (10 M)-treated Jurkat cells were assessed for migration toward 100 ng/ml CXCL12 using a neuroprobe chemotaxis chamber as described above. The migration assay shown is a representative of three independent experiments and is presented as mean Ϯ SEM (*, PϽ0.01, compared with control CXCL12-treated Jurkat cells). (C) Jurkat T cells and Lck-deficient J.CaM 1.6 cells were tested for their ability to migrate to CXCL12. Media containing different concentrations of CXCL12 (as indicated) were placed in the lower chamber, and the number of cells that migrated to the lower chamber was counted as described above. The migration assay shown is an average of three independent experiments and is presented as mean Ϯ SEM (*, PϽ0.01, compared with CXCL12-treated J.CaM 1.6 cells). (D) Jurkat and J.CaM 1.6 cells were examined for cell-surface expression of CXCR4 by flow cytometry using the CXCR4-specific antibody 12G5 and a FITC-conjugated secondary antibody. Fluorescence intensity of the cells using a CXCR4 antibody (red solid line) was compared with an isotype (IgG2 a ) control antibody (green dotted line). FL2, Fluorescence 2.
Myristoylation and palmitoylation of Hck are required to restore CXCL12-mediated chemotaxis
To assess the possibility that the two isoforms of Hck have different biological activity and whether the localization of Hck to lipid rafts was biologically important in CXCL12-mediated chemotaxis, we used a number of different Hck alleles (Fig.  3A) . In the case of p59
Hck , we used two mutant alleles (Fig.  3A) . The first contains a cysteine-to-serine mutation at amino acid three (C3S) and is defective in palmitoylation, and the glycine-to-alanine mutation at amino acid 2 (G2A) renders them deficient in myristoylation and palmitoylation. Although the cysteine is still present in the Gly-Ala allele, it is not palmitoylated as a result of the fact that myristoylation is a prerequisite for palmitoylation to occur [19] . Although p59 Hck wild-type protein is associated with lipid rafts, both mutants are defective in lipid raft association [19] . In the case of p61
Hck , we used a gain-of-acylation allele that has a Gly-to-Cys substitution at amino acid 3 (p61 G3C) and thus, is analogous to the extreme N terminus of p59
Hck , resulting in a p61 protein that contains myristic and palmitic acid moieties [19] . Furthermore, only the dually acylated version of p61
Hck is associated with lipid rafts [19] . As our previous analysis of these mutant Hck proteins was in murine fibroblasts, we needed to establish whether they were appropriately targeted in the J.CaM 1.6 cells. The lipid raft fraction was isolated from J.CaM 1.6 cells that were stably expressing the various cDNA constructs described in Figure 3A . As predicted, p59
Hck wild-type protein was localized within the lipid raft fraction of J.CaM 1.6 cells, whereas both mutant proteins (p59 C3S and p59 G2A) were not (Fig. 3B ). There was a small amount of the p59 C3S protein detected in the lipid raft fraction, but compared with the total protein levels, this was minor. With respect to the p61
Hckexpressing J.CaM 1.6 cells, monoacylated and dually acylated p61 proteins were present in the membrane fraction (data not shown). Although p61
Hck was not detected in the lipid raft fraction, the mutant allele that is myristoylated and palmitoylated (p61 G3C) was detected in both fractions, including the lipid raft fraction (Fig. 3B ). Flotillin-2 was used as a lipid raft-specific marker to assess the purity of the isolated fractions (Fig. 3B) . These data show that we could use these Hck cDNA constructs to assess whether lipid raft localization of SFK was necessary for CXCL12-mediated chemotaxis.
Although p59 Hck wild-type-expressing J.CaM 1.6 clones were all responsive to CXCL12 (Figs. 2 and 4A) , both p59 Hck mutant alleles were unable to restore CXCL12-mediated chemotaxis, despite the high expression levels by the cells (Fig.  4A) . Although expression of p61
Hck wild-type was unable to restore chemotaxis of the J.CaM 1.6 cells, the mutant p61 Hck allele (p61 G3C), which is myristoylated and palmitoylated, was able to completely rescue the ability of the J.CaM 1.6 cells to respond to CXCL12 (Fig. 4B) . Taken together, these data are consistent with the hypothesis that it is the raft localization of SFK and not its specific identity that is important in CXCL12-mediated chemotaxis. It should be noted that in all of the Hck-expressing J.CaM 1.6 clones, the level of CXCR4 that is expressed on the cell surface is comparable as determined by flow cytometry. In addition, the ability for CXCR4 to be downregulated from the cell surface in the presence of ligand was also similar in all of the clones analyzed, suggesting that CXCR4 internalization is SFK-independent ( Supplementary  Fig. 3 ). This would also imply that the mere ligand-dependent internalization of CXCR4 is not sufficient to mediate chemotaxis.
Lipid raft association of SFK is required for CXCL12-mediated chemotaxis
To further assess whether lipid raft association of SFK is required in CXCL12 responsiveness, wild-type p59
Hck -expressing J.CaM 1.6 cells were treated with M␤CD at concentrations (10 mM and 25 mM) that did not affect cell viability, as determined by trypan blue exclusion assay (data not shown). Although the treatment of cells with M␤CD to act as a cholesterol sequestration agent did not have an effect on the total p59
Hck protein levels (Fig. 5A) , it resulted in a decreased Hck and p61 Hck wild-type (WT) proteins were tested for their ability to migrate toward CXCL12 (100 ng/ml) as described in Figure 1 . The migration assay shown is a representative of six independent experiments. Migration data are represented as mean Ϯ SEM (*, PϽ 0.01, compared with CXCL12-treated J.CaM 1.6 cells). (B) The levels of Hck protein expressed in the individual clones were assessed by Western blotting with a Hck-specific mAb. The Western blot was reprobed with an actin-specific antibody as a loading control. U937 cell extract (ϩ) was used as a positive control, as it expresses p59
Hck and p61
Hck isoforms.
association of the dually acylated p59 Hck to the lipid raft fraction in a dose-dependent manner (Fig. 5B) . Consistent with other studies, we observed that the location of flotillin to the lipid raft is relatively unaffected by M␤CD treatment [39] . Although the levels of p59
Hck were diminished in the lipid raft fractions isolated from M␤CD-treated cells, we did not observe a concomitant increase in the soluble fractions. As the total Hck protein levels remained the same, we attribute this to the large dilution of the protein in the soluble fraction. Concomitant with the decrease lipid raft association of p59 Hck , we found a significant decrease in the ability of M␤CD-treated cells to migrate toward CXCL12 (Fig. 5C ). This decrease was not a result of a direct inactivation of CXCL12 by M␤CD, as CXCL12, which was preincubated with M␤CD prior to its addition in the assay, was still able to mediate chemotaxis (data not shown). Accumulatively, these results show that appropriate targeting of SFK to lipid rafts is required for CXCL12-mediated chemotaxis.
DISCUSSION
In this report, we have demonstrated that dual acylation and lipid raft association of SFK are crucial for CXCL12-mediated chemotaxis in human T cells. The requirement of SFK for chemotaxis was shown in previous studies [15, 40, 41] , although the specificity of the SFK was under some debate [9, 10] . We first demonstrated that several SFK-selective inhibitors (PP1, PP2, and SU6656) were able to dramatically decrease chemotaxis toward CXCL12 in a human myelomonocytic cell line (U937) and a human T cell line (Jurkat). These results were further confirmed in our assays with the Lckdeficient J.CaM 1.6 cell line. As a result of differences in reports of the ability of J.CaM 1.6 cells to respond to CXCL12 [6, 9 , 10], we tested several doses of CXCL12. It was found that J.CaM 1.6 cells are consistently compromised in their ability to respond to CXCL12, and this difference is not the result of reduced CXCR4 receptor surface expression. We then examined if restoration of SFK in the J.CaM 1.6 cells will result in responsiveness to CXCL12. Using Hck as a model SFK, which has two naturally occurring isoforms that differ in their amino terminal acylations, we were able to establish that only the dually acylated isoform p59
Hck was able to restore chemotactic response to CXCL12. There is now an emerging theme to suggest that specific localization of signaling molecules, including receptors and downstream effectors within the plasma membrane, is important in regulating biological responses. Herein, we determined that the specific targeting of the SFK to the appropriate localization was necessary to mediate chemotaxis. We used several mutant alleles of p59
Hck and p61 Hck to test our hypothesis. Loss of dual acylation resulted in the inability to rescue the chemotactic defect, whereas gain of dual acylation resulted in lipid raft association of SFK and completely restored chemotactic response to CXCL12. Our data agree with other reports describing the essential role of SFK in mediating cell migration. This includes their roles in CCL11- and Triton X-100-soluble (s) fractions were isolated from J.CaM 1.6 cells that were stably expressing the various Hck alleles listed in A by linear sucrose gradient centrifugation as described in Materials and Methods. Equal volumes of each fraction were analyzed by Western blotting using the Hck-specific antibody. Flotillin-2 was used as a lipid raft-specific marker. The Western blot presented is a representative of three independent experiments. induced chemotaxis through CCR3 [42] , chemotaxis to leukotriene B4 [43] , as well as in CCR5 signaling responses to CCL4 [44] . In addition, it has been shown that there is reduction in neutrophil migration in mice that are deficient for the SFK, Hck, and Fgr, consistent with a role for these kinases in neutrophil migration in vivo [14] .
Our studies complement several studies in which lipid raft association of signaling molecules is essential in mediating specific biological responses. In TCR-mediated signaling, the SFK, Lck, and Fyn are essential, and mere membrane association of the Lck and Fyn is not sufficient to mediate TCR signaling. Their specific localization to lipid rafts is required for their ability to function in TCR signaling [45, 46] . In addition, it has been shown recently that palmitoylation of the transmembrane protein Fas is required for efficient death signaling [47] . Localization of receptors and signaling effectors to lipid rafts has been shown to be important for a number of receptor systems [24] .
In summary, we found Hck is able to rescue a Lck-deficient T cell line with respect to its ability to respond to the chemokine CXCL12. Interestingly, only isoforms of Hck that contained myristic and palmitic acid were able to restore migration in the Lck-deficient J.CaM 1.6 cells. Previous studies analyzing the role of SFK in the role of migration have at best pointed to its role in terms of the "kind" of SFK is involved [6, 9, 10] . Here, we have shown for the first time that dual acylation and lipid raft association of SFK are requirements of CXCL12-mediated chemotaxis. As long as the SFK examined was targeted to the raft, it resulted in the restoration of migration in response to CXCL12. This suggests that the unique microenvironment of these membrane microdomains provides specificity to a particular extracellular signal, such as CXCL12. Disruption of these domains by sequestering plasma membrane cholesterol abrogated chemotaxis to CXCL12. These membrane microdomains act as dynamic entities that coordinate signaling proteins spatially and temporally in response to various stimuli [24] . The compartmentalization of raft-associated proteins and nonraft proteins allows signaling molecules to access various signaling pathways resulting in functional specificity.
Consistent with a role for lipid rafts in CXCL12 chemotaxis, its cognate receptor CXCR4 has been shown to be localized in biochemically isolated lipid raft fractions as well as to colocalize with lipid raft markers at the leading edge of migrating leukocytes [26, 28, 31, 48] . Our current working model would be that CXCL12 binds to the raft-associated CXCR4 or that binding of the chemokine to its receptor translocates the receptor to lipid rafts, where it can interact with and activate downstream effectors, including the dually acylated SFK (Fig.  6) . Recently, it has been shown that the lipid raft resident protein flotillin-1, which is also recruited to lipid rafts in response to CXCL12, plays a critical role in CXCR4 signaling and function [48] . A key question that remains is what the key functional substrates are for the SFK within the lipid rafts that mediate chemotaxis. There is evidence to show that c-Cbl and Cbl-b [5, 6] and Dok [8] are required for CXCL12-mediated Hck and mutant alleles or (B) p61 Hck wild-type and mutant alleles described in Figure 3A were assayed for their ability to migrate toward CXCL12 (100 ng/ml). The chemotaxis assays were performed as described before, and the data shown are representative of three independent experiments. Migration data are represented as mean Ϯ SEM (*, PϽ0.01, compared with CXCL12-treated J.CaM 1.6 cells). Western blots have been included in the lower panels to illustrate Hck protein levels using actin as a loading control.
chemotaxis, all of which have been shown to be cellular targets of the SFK [49, 50] , but the requirement for raft association has not been addressed thus far. The unique raft association of CXCL12/CXCR4 signaling may also help explain how the TCR signaling pathways cross-talk [33, 51] , as they both could be localized in close proximity within the same membrane microdomains.
The observations made in this study provide the interesting possibility for therapeutic intervention in pathophysiological conditions in which the CXCL12/CXCR4 axis is altered or elevated. Inhibition of the axis such as the use of SFK inhibitors may be useful in controlling the metastatic behavior of different cancers that use CXCL12 as a homing mechanism such as breast cancer [52, 53] , renal cell carcinoma [54] , rhabdomyosarcoma [55] , prostate cancer [56] , and multiple myeloma [57] [58] [59] . In contrast, there may be situations in which it is desired to enhance the CXCL12/CXCR4 axis, such as in the CXCL12-dependent homing and engraftment of stem cells into the bone marrow after transplantation [60] . Furthermore, agents that disrupt lipid raft structure or integrity may also impact chemokine signaling, albeit in unknown ways.
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Hck -expressing cells as described before, and the data shown are an average of four independent experiments. Migration data are represented as mean Ϯ SEM (*, PϽ0.01, compared with CXCL12-treated, p59
Hck -expressing J.CaM 1.6 cells). Fig. 6 . A schematic illustration of the working model that dual acylation of SFK and their lipid raft association are required for CXCL12-mediated chemotaxis. CXCR4 is depicted as a seven-transmembrane receptor that is localized to the plasma membrane lipid rafts and thus, activates the SFK that are lipid raft residents based on their dual acylation within their extreme N terminus. This specific subcellular localization is required for chemotaxis toward the CXCL12 chemokine.
